Genocea Provides Fourth Quarter 2019 Corporate Update

NEXT STORY
Flow Cytometry Market to Grow at a CAGR of 8.2% to Reach $6.4 Billion by 2027 with the Growing Funding for Various Clinical Trial Projects – Exclusive Report by Meticulous Research®
PREV STORY
Antimicrobial Susceptibility Testing Market Worth $5.09 billion by 2027 – Exclusive Report by Meticulous Research®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EyePoint Pharmaceuticals Secures Pass-through Payment Status and Assignment of C-Code for DEXYCU™

WATERTOWN, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical ...

author_avatar
NASDAQ Market News

Curis Reports First Quarter 2016 Financial Results

LEXINGTON, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

author_avatar
NASDAQ Market News

CORRECTING and REPLACING – Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma

Seven Cancer Centers in United States Open for Enrollment in Amended Trial NEW YORK, ...

author_avatar
NASDAQ Market News